Ligand-based targeted therapy for cancer tissue (Q37425224)

20 August 2017

1 reference

title

Ligand-based targeted therapy for cancer tissue (English)

1 reference

20 August 2017

Manasi Das

1

1 reference

20 August 2017

Chandana Mohanty

series ordinal

2

1 reference

20 August 2017

Sanjeeb K Sahoo

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

Expert Opinion on Drug Delivery

20 August 2017

published in

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

285-304

1 reference

Drug delivery systems: entering the mainstream

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanoparticle and targeted systems for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Small-scale systems for in vivo drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanotech approaches to drug delivery and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted drug delivery in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted pharmaceutical nanocarriers for cancer therapy and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

By-passing of P-glycoprotein using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Liposome-based approaches to overcome anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Clinical trials of P-glycoprotein reversal in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The reversal of multidrug resistance: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Gene therapy to overcome drug resistance in cancer: targeting key regulators of the apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanotechnology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The present and future of nanotechnology in human health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanomedicine--prospective therapeutic and diagnostic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanomedicine: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted polymeric micelles for delivery of poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Biodegradable long-circulating polymeric nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted drug conjugates: principles and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Lymphatic targeting with nanoparticulate system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Soluble and cell-associated transferrin receptor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Ligand based dendritic systems for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Radioimmunochemical measurement of the transferrin receptor in human trophoblast and reticulocyte membranes with a specific anti-receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Active tumor-targeted delivery of PEG-protein via transferrin-transferrin-receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Folate receptor-targeted drugs for cancer and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Design of folic acid-conjugated nanoparticles for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Lectins as bioactive plant proteins: a potential in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Characterization of lectin-mediated brain uptake of HIV-1 GP120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Lectin-mediated drug targeting: history and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by caco-2 monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

EGFR gene amplification--rearrangement in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Receptor tyrosine kinase signalling as a target for cancer intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Ligand liposomes and boron neutron capture therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Amplified delivery of indium-111 to EGFR-positive human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nuclear localization of EGF receptor and its potential new role as a transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Recombinant immunotoxins in targeted cancer cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted therapies in breast cancer: established drugs and recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Biodegradable nanoparticles for direct or two-step tumor immunotargeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Preparation and Characterization of Paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Antibody engineering, virus retargeting and cellular immunotherapy: one ring to rule them all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Adeno-associated virus serotypes: vector toolkit for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Aptamers against extracellular targets for in vivo applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Escort aptamers: a delivery service for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanoparticle-aptamer bioconjugates for cancer targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Discovery and development of anticancer aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Cancer cell targeting using multiple aptamers conjugated on nanorods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Improved QD-BRET conjugates for detection and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

EGF receptor variant III as a target antigen for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Molecular targeting of drug delivery systems to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

LHRH receptor targeted therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Intracellular delivery of nanoparticles of an antiasthmatic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Nanotechnology safety concerns revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240902780166

10.1517/17425240902780166

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference